Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. STXS
STXS logo

STXS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

STXS News

Stereotaxis to Acquire Robocath for Up to $45 Million

4d agoYahoo Finance

Stereotaxis Acquires Robocath to Enhance Surgical Robotics for Cardiology

5d agoNASDAQ.COM

Stereotaxis to Acquire France's Robocath for $20M

5d agoseekingalpha

Stereotaxis Receives FDA Clearance for Synchrony System

Apr 06 2026NASDAQ.COM

Stereotaxis Secures FDA 510(k) Clearance for Synchrony System

Apr 06 2026NASDAQ.COM

Stereotaxis Receives FDA Clearance for Synchrony System

Apr 06 2026Newsfilter

Stereotaxis Receives FDA Clearance for Synchrony System Launch

Apr 06 2026seekingalpha

DAFNA Capital Management Reduces Stake in Biotechnology ETF

Mar 21 2026NASDAQ.COM

DAFNA Capital Management Reduces Stake in iShares Biotechnology ETF

Mar 21 2026Fool

Stereotaxis Reports 36% Revenue Growth in Q4

Mar 10 2026Yahoo Finance

Stereotaxis Q4 2025 Earnings Call Insights

Mar 10 2026seekingalpha

Stereotaxis Q4 Earnings Report Analysis

Mar 09 2026seekingalpha

Stereotaxis to Announce Q4 Earnings on March 9th

Mar 06 2026seekingalpha

Stereotaxis Receives FDA Approval for MAGiC Magnetic Ablation Catheter

Jan 06 2026NASDAQ.COM

Stereotaxis Receives FDA Approval for MAGiC Catheter, Advancing Cardiac Treatment Technology

Jan 06 2026Globenewswire

Key Analyst Recommendations for Tuesday: Nvidia, Tesla, Roku, Estee Lauder, Southwest, Gap, MetLife, and Others

Dec 16 2025CNBC